US4162303A
(en)
*
|
1977-06-17 |
1979-07-24 |
Sanders Murray J |
Potency and atoxicity test for modified neurotoxin
|
US4126676A
(en)
*
|
1977-07-22 |
1978-11-21 |
Sanders Murray J |
Modified neurotoxin derived from naja genus snake venom
|
US4292308A
(en)
*
|
1979-08-21 |
1981-09-29 |
Biotherapeutics, Inc. |
Treatment of animals exposed to or subject to exposure to organophosphate animal poisonous nerve agents
|
US4672107A
(en)
*
|
1985-04-15 |
1987-06-09 |
Inbex, Inc. |
Cell growth inhibitor and method
|
US5565431A
(en)
*
|
1994-06-20 |
1996-10-15 |
Lipps; Binie V. |
Cancer cell inhibitors and method
|
CA2253937A1
(en)
|
1996-05-10 |
1997-11-20 |
Phylomed Corporation |
Methods for oxidizing disulfide bonds using ozone
|
BG65618B1
(en)
*
|
2003-01-22 |
2009-03-31 |
Борис Алексиев |
Use of anti-snake venom serum for cerebral insult treatment
|
US20050031608A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Paul Reid |
Modified alpha-neurotoxins as painkillers
|
US20050255097A1
(en)
*
|
2004-01-26 |
2005-11-17 |
Paul Reid |
Modified venom and venom components as anti-retroviral agents
|
US20060045875A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Reid Paul F |
Method of use of crotoxin as an anti-retroviral agent
|
US8034777B2
(en)
*
|
2004-09-23 |
2011-10-11 |
Receptopharm, Inc. |
Modified anticholinergic neurotoxins as modulators of the autoimmune reaction
|
US20060088843A1
(en)
*
|
2004-10-25 |
2006-04-27 |
Reid Paul F |
Modified venom and venom components as anti-retroviral agents
|
US20060088858A1
(en)
*
|
2004-10-25 |
2006-04-27 |
Reid Paul F |
Modified venom and venom components as anti-retroviral agents
|
DE102004055891B4
(en)
|
2004-11-19 |
2007-08-30 |
Wiesner, Henning, Prof., Dr. |
Mixtures of snake venoms for disease control
|
US7902152B2
(en)
*
|
2005-12-20 |
2011-03-08 |
Receptopharm, Inc. |
Use of cobratoxin as an analgesic
|
AR061669A1
(en)
|
2006-06-29 |
2008-09-10 |
Merz Pharma Gmbh & Co Kgaa |
HIGH FREQUENCY THERAPY APPLICATION WITH BOTULIN TOXIN
|
US10792344B2
(en)
|
2006-06-29 |
2020-10-06 |
Merz Pharma Gmbh & Co. Kgaa |
High frequency application of botulinum toxin therapy
|
US20080081048A1
(en)
*
|
2006-10-02 |
2008-04-03 |
Laurence Raymond |
Production of modified neurotoxins
|
US7259237B1
(en)
*
|
2006-12-29 |
2007-08-21 |
Miller Kent D |
Pan-antiviral peptides
|
US9220743B2
(en)
|
2010-01-22 |
2015-12-29 |
Nuovo Biologics, Llc |
Pan-antiviral peptides for protein kinase inhibition
|